Lionhunter Capital Management’s TriSalus Life Sciences TLSI Stock Holding History
Bought
Maintained
Sold
Other funds holding TLSI
Lionhunter Capital Management's TLSI Position: Q3 2026 in Review
Lionhunter Capital Management sold out of TriSalus Life Sciences (TLSI) in Q3 2026, closing a stake of 300,275 shares — an estimated $1.37M sold.
Lionhunter Capital Management first reported a position in TLSI in Q2 2026 and held it in 1 quarter. The position peaked at $1.37M in Q2 2026. 81 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.
- Lionhunter Capital Management reported no remaining TriSalus Life Sciences position as of Q3 2026 after selling out during the quarter.
- Lionhunter Capital Management sold 300,275 TriSalus Life Sciences shares in Q3 2026, an estimated $1.37M.
- Lionhunter Capital Management first reported a position in TriSalus Life Sciences in Q2 2026 and held it in 1 quarter.
- Lionhunter Capital Management's TriSalus Life Sciences position peaked at $1.37M in Q2 2026.
- 81 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.
Based on Lionhunter Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.